ArticleEClinicalMedicine2026

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Vasileios Fragoulakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.